Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

52 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Ground state proton capture reactions from 20 to 100 MeV.
Hausman HJ, Blatt SL, Donoghue TR, Kalen J, Kim W, Marchlenski DG, Rackers TW, Schmalbrock P, Kovash MA, Bacher AD. Hausman HJ, et al. Among authors: kalen j. Phys Rev C Nucl Phys. 1988 Feb;37(2):503-511. doi: 10.1103/physrevc.37.503. Phys Rev C Nucl Phys. 1988. PMID: 9954468 No abstract available.
Radiative proton capture to excited states in 16O.
Kalen JD, Hausman HJ, Abduljalil A, Kim W, Marchlenski DG, McDermott JP, Rackers TW, Blatt SL, Kovash MA, Bacher AD. Kalen JD, et al. Phys Rev C Nucl Phys. 1989 Feb;39(2):340-346. doi: 10.1103/physrevc.39.340. Phys Rev C Nucl Phys. 1989. PMID: 9955208 No abstract available.
Proton radiative capture by 15N, 16O, 27Al, and 28Si.
Rackers TW, Blatt SL, Donoghue TR, Hausman HJ, Kalen J, Kim W, Marchlenski DG, Wiescher M, Kovash MA, Bacher AD. Rackers TW, et al. Among authors: kalen j. Phys Rev C Nucl Phys. 1988 Apr;37(4):1759-1761. doi: 10.1103/physrevc.37.1759. Phys Rev C Nucl Phys. 1988. PMID: 9954632 No abstract available.
2H induced reactions on 8Li and primordial nucleosynthesis.
Balbes MJ, Farrell MM, Boyd RN, Gu X, Hencheck M, Kalen JD, Mitchell CA, Kolata JJ, Lamkin K, Smith R, Tighe R, Ashktorab K, Becchetti FD, Brown J, Roberts D, Wang T, Humphreys D, Vourvopoulos G, Islam MS. Balbes MJ, et al. Among authors: kalen jd. Phys Rev Lett. 1993 Dec 13;71(24):3931-3934. doi: 10.1103/PhysRevLett.71.3931. Phys Rev Lett. 1993. PMID: 10055111 No abstract available.
Metastatic organotropism in small cell lung cancer.
Krishnamurthy M, Dhall A, Schultz CW, Baird MA, Desai P, Odell J, Sahoo S, Takahashi N, Nirula M, Zhuang S, Huang Y, Schroeder B, Zhang Y, Thomas MS, Redon C, Robinson C, Thang L, Ileva L, Patel NL, Kalen JD, Varlet AA, Zuela-Sopilniak N, Jha A, Wangsa D, Butcher D, Morgan T, Afzal AN, Chari R, Baktiar K, Kumar S, Pongor L, Difilippantonio S, Aladjem MI, Pommier Y, Jolly MK, Lammerding J, Sharma AK, Thomas A. Krishnamurthy M, et al. Among authors: kalen jd. bioRxiv [Preprint]. 2024 Oct 8:2024.10.07.617066. doi: 10.1101/2024.10.07.617066. bioRxiv. 2024. PMID: 39416100 Free PMC article. Preprint.
Targeting NAD+ Metabolism Vulnerability in FH-Deficient Hereditary Leiomyomatosis and Renal Cell Carcinoma with the novel NAMPT Inhibitor OT-82.
Najera SS, Ricketts CJ, Schmidt LS, Medina JI, Saito K, Ileva L, Brender JR, James AM, Peer CJ, Gouker B, Karim BO, Chernova O, Wells C, Wei MH, Yang Y, Zhang X, Klumpp-Thomas C, Travers J, Chen L, Wilson KM, Issaq SH, Figg WD, Difilippantonio S, Kalen JD, Krishna MC, Thomas CJ, Ceribelli M, Heske CM, Crooks DR, Meier JL. Najera SS, et al. Among authors: kalen jd. Mol Cancer Ther. 2024 Oct 14. doi: 10.1158/1535-7163.MCT-24-0225. Online ahead of print. Mol Cancer Ther. 2024. PMID: 39397296
Toward a CRISPR-based mouse model of Vhl-deficient clear cell kidney cancer: Initial experience and lessons learned.
Stransky LA, Gao W, Schmidt LS, Bi K, Ricketts CJ, Ramesh V, James A, Difilippantonio S, Ileva L, Kalen JD, Karim B, Jeon A, Morgan T, Warner AC, Turan S, Unite J, Tran B, Choudhari S, Zhao Y, Linn DE, Yun C, Dhandapani S, Parab V, Pinheiro EM, Morris N, He L, Vigeant SM, Pignon JC, Sticco-Ivins M, Signoretti S, Van Allen EM, Linehan WM, Kaelin WG Jr. Stransky LA, et al. Among authors: kalen jd. Proc Natl Acad Sci U S A. 2024 Oct 8;121(41):e2408549121. doi: 10.1073/pnas.2408549121. Epub 2024 Oct 4. Proc Natl Acad Sci U S A. 2024. PMID: 39365820 Free PMC article.
Preclinical Therapeutic Efficacy of RAF/MEK/ERK and IGF1R/AKT/mTOR Inhibition in Neuroblastoma.
Stauffer S, Roth JS, Hernandez ER, Kowalczyk JT, Sealover NE, Hebron KE, James A, Isanogle KA, Riffle LA, Ileva L, Luo X, Chen JQ, Kedei N, Kortum RL, Lei H, Shern JF, Kalen JD, Edmondson EF, Hall MD, Difilippantonio S, Thiele CJ, Yohe ME. Stauffer S, et al. Among authors: kalen jd. Cancers (Basel). 2024 Jun 25;16(13):2320. doi: 10.3390/cancers16132320. Cancers (Basel). 2024. PMID: 39001383 Free PMC article.
A dual-luciferase bioluminescence system for the assessment of cellular therapies.
Torres Chavez AG, McKenna MK, Balasubramanian K, Riffle L, Patel NL, Kalen JD, St Croix B, Leen AM, Bajgain P. Torres Chavez AG, et al. Among authors: kalen jd. Mol Ther Oncol. 2024 Jan 10;32(1):200763. doi: 10.1016/j.omton.2024.200763. eCollection 2024 Mar 21. Mol Ther Oncol. 2024. PMID: 38596291 Free PMC article.
52 results